RecruitingNot ApplicableNCT03710902

Empowerment and Mobile Technology in the Control of Cardiovascular Risk Factors in Patients With Ischemic Stroke


Sponsor

Jukka Putaala

Enrollment

405 participants

Start Date

Oct 17, 2018

Study Type

INTERVENTIONAL

Conditions

Summary

The CARDIOSTROKE is a randomized trial comparing mobile-device assisted control of hypertension together with screening of occult atrial fibrillation to standard care in patients with recent ischemic stroke or transient ischemic attack.


Eligibility

Min Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This trial is testing whether a mobile phone-based empowerment program can help stroke survivors better manage their blood pressure and reduce the risk of having another stroke, by making it easier to monitor blood pressure and stay on track with medications. **You may be eligible if...** - You are 40 or older - You have had an ischemic stroke (a stroke caused by a blocked blood vessel) or a mini-stroke (TIA), with a severity score of 3 or higher - You have been diagnosed with high blood pressure (either pre-existing or newly found) - You or your legal representative can give informed consent **You may NOT be eligible if...** - You have a known heart condition that is the primary source of clots (like atrial fibrillation) - You are already taking blood thinners (anticoagulants) or there is a reason you need them - You have a pacemaker - You are unable or unwilling to follow study activities - You have a serious medical condition that would interfere with participation Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTECG monitoring for 3 weeks

A 3-week continuous ECG monitoring to detect occult AF.

OTHERSelf-monitoring of BP and self-titration of antihypertensive medication

One-week monthly self-monitoring of BP and self-titration of antihypertensive medication according to a pre-specified protocol, assisted with a mobile device application.


Locations(4)

Kanta-Häme Central Hospital

Hämeenlinna, Finland

Helsinki University Hospital

Helsinki, Finland

Hyvinkää Hospital

Hyvinkää, Finland

Päijät-Häme Central Hospital

Lahti, Finland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03710902


Related Trials